Hesperos And UCF Develop iPSC-Derived Myelination Model
24 Oct 2024 //
BUSINESSWIRE
Hesperos Appoints Lawrence Florin As CEO To Lead Growth
22 Oct 2024 //
BUSINESSWIRE
Hesperos Supports Phase II Trial with Human-on-a-Chip® Technology
24 Sep 2024 //
BUSINESSWIRE
NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform
07 May 2024 //
BUSINESSWIRE
Hesperos, Inc. Appoints New Chief Executive Officer, Dr. James Kronauge
26 May 2022 //
BUSINESSWIRE